US OptionsDetailed Quotes

NUVB240816C5000

Watchlist

0.35
0.000.00%

15min DelayClose Jul 23 10:59 ET

0.00High0.00Low

Nuvation Bio Stock Discussion

Trytosaveabit

Jun 26 16:16

Insider buy! Or should I say MORE buys! Hehehe

$Nuvation Bio(NUVB.US)$ Director Cui Xiangmin purchased 277.9K shares of common stock on Jun 25, 2024 at an average price of $2.97 for a total value of $825.35K.

Trytosaveabit

Jun 25 17:33

Insider buy

$Nuvation Bio(NUVB.US)$ Director Cui Xiangmin purchased 500K shares of common stock on Jun 20, 21, 24, 2024 at an average price of $2.98 for a total value of $1.49 million.

Trytosaveabit

Jun 3 04:00

Watching!

$Nuvation Bio(NUVB.US)$ Reported Saturday, Nuvation Bio Revealed Findings From The Crucial Phase 2 TRUST-I Trial Of Their Experimental ROS1 Inhibitor, Taletrectinib At The ASCO 2024
Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of those who were ROS1 TKI-pretreated in the study
Responses were durable with long-term follow-up; 71% of TKI-naïve patients were still progression-free at two years
TRUST-I is one of t...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

Jaguar8

Apr 10 15:04

$Nuvation Bio(NUVB.US)$
NEWS
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
Nuvation Bio completes the acquisition of AnHeart Therapeutics, transforming into a late-stage global oncology company. Shareholders now own approximately 67% and 33% of NUVB, setting the stage for potential commercial success by 2025.

Meltyy

Mar 25 21:43

🔥 M&A News 🔥

$AbbVie(ABBV.US)$ to acquire $Landos Biopharma(LABP.US)$
⇒ $137.5M deal at $20.42/sh 💰💰
⇒ strengthens portfolio in inflammatory & autoimmune diseases
⇒ Adds lead asset NX-13 (Ph2 trial UC)
$Nuvation Bio(NUVB.US)$ to acquire AnHeart Therapeutics
⇒ all-stock transaction
⇒ transforms NUVB into late-stage global oncology company
⇒ Includes taletrectinib with ongoing trials NSCLC)
$Novo-Nordisk A/S(NVO.US)$ to acquire Cardior Pharmaceuticals
⇒ 1.025 B euros deal 💰💰
⇒ strengthens pi...

Moomoo Breakfast US

Jun 27, 2022 07:09

ColumnsToday's pre-market stock movers: BNTX, JBLU, DWAC, SAVE and more

Gainers:
• $Axsome Therapeutics(AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics(CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...

Analysts Notebook

May 4, 2022 05:58

ColumnsTop upgrades and downgrades on 5/4

Upgrades
• $Companhia Brasileira De Distribuicao(CBD.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $5.25
• $Hexcel(HXL.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $65 (from $45)
• $IPG Photonics(IPGP.US)$ : Citigroup Upgrades to Buy from Neutral - PT $157
• $Livent(LTHM.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $33 (from $25)
• $Premier(PINC.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $45 (from $...

No comment yet